Osteosarcoma: 25 year survival rate significantly improved with adjuvant chemotherapy

Study Type:Therapy

OE Level Evidence:2

Journal Level of Evidence:N/A

Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma

Cancer. 2012 Dec 1;118(23):5888-93

Contributing Authors: NM Bernthal N Federman FR Eilber SD Nelson JJ Eckardt FC Eilber WD Tap

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

No credit card required

JOIN Forgot Password?

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.